Plasmacytoid dendritic cell
Case Report CD31 is a surrogate marker for blastic plasmacytoid dendritic cell neoplasm: a case of a hematologic skin tumor immunohistochemically false negative for CD45
7
Blastic plasmacytoid dendritic cell neoplasm: challenges and future prospects
9
Case Report Sustained complete remission of a limited-stage blastic plasmacytoid dendritic cell neoplasm followed by a simultaneous combination of low-dose DeVIC therapy and radiation therapy: a case report and review of the literature
6
Exploring the effect of chidamide on blastic plasmacytoid dendritic cell neoplasm: a case report and literature review
5
Case Report Lymph blastic plasmacytoid dendritic cell neoplasm: a case report and review of literature
5
<p>Tagraxofusp for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A Brief Report on Emerging Data</p>
7
Case Report A case of blastic plasmacytoid dendritic cell neoplasm with ecchymotic lesions on the whole body
9
Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation- associated immunophenotypic profile
13
<p>Case Report of Anti-CD123 Chimeric Antigen Receptor T-Cell Therapy Followed by Radiotherapy for a Recurrence of Blastic Plasmacytoid Dendritic Cell Neoplasm After Allogeneic Hematopoietic Stem Cell Transplantation</p>
6
Characterization of the Plasmacytoid Dendritic Cell Response to Transmitted/Founder and Nontransmitted Variants of HIV-1
10
Plasmacytoid Dendritic Cell Dynamics and Alpha Interferon Production during Simian Immunodeficiency Virus Infection with a Nonpathogenic Outcome
8
HIV-1 Env and Nef Cooperatively Contribute to Plasmacytoid Dendritic Cell Activation via CD4-Dependent Mechanisms
8
TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells
16
Plasmacytoid Dendritic Cell Infection and Sensing Capacity during Pathogenic and Nonpathogenic Simian Immunodeficiency Virus Infection
10
Peripheral Blood CD4 T-Cell and Plasmacytoid Dendritic Cell (pDC) Reactivity to Herpes Simplex Virus 2 and pDC Number Do Not Correlate with the Clinical or Virologic Severity of Recurrent Genital Herpes
12
Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
20
New application of anti-TLR monoclonal antibodies: detection, inhibition and protection
8
Early detection of transformation to BPDCN in a patient with MDS
5
Plasmacytoid dendritic cells promote HIV 1–induced group 3 innate lymphoid cell depletion
13
Plasmacytoid Dendritic Cells Reduce HIV Production in Elite Controllers
8